Submitted by Anonymous (not verified) on 24 February 2026 - 15:32
Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 21, Status: Authorised